Clinical Trial Update: OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI

View source ↗

Summary

The trial update describes a study evaluating whether OBT measurements on MRI can differentiate the presence versus absence of hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Beijing 302 Hospital | Conditions: HCC | Status: UNKNOWN